Filomena Maiese moves from ASMI to iNova

31 January 2018 - Deborah Wilkes


Filomena Maiese is leaving the Australian Self Medication Industry (ASMI) to join iNova Pharmaceuticals as executive director of portfolio strategy and innovation.

Click tags below for more information on topics:

iNova CHP Australia

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: